These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 23300021)

  • 1. Non-hodgkin lymphoma and circulating markers of inflammation and adiposity in a nested case-control study: the multiethnic cohort.
    Conroy SM; Maskarinec G; Morimoto Y; Franke AA; Cooney RV; Wilkens LR; Goodman MT; Hernadez BY; Le Marchand L; Henderson BE; Kolonel LN
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):337-47. PubMed ID: 23300021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediagnostic serum tocopherol levels and the risk of non-hodgkin lymphoma: the multiethnic cohort.
    Morimoto Y; Ollberding NJ; Cooney RV; Wilkens LR; Franke AA; Le Marchand L; Goodman MT; Hernandez BY; Kolonel LN; Maskarinec G
    Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2075-83. PubMed ID: 24045922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphoma.
    Purdue MP; Lan Q; Bagni R; Hocking WG; Baris D; Reding DJ; Rothman N
    Cancer Res; 2011 Jul; 71(14):4898-907. PubMed ID: 21632552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines in serum in relation to future non-Hodgkin lymphoma risk: evidence for associations by histologic subtype.
    Edlefsen KL; Martínez-Maza O; Madeleine MM; Magpantay L; Mirick DK; Kopecky KJ; LaCroix AZ; De Roos AJ
    Int J Cancer; 2014 Aug; 135(4):913-22. PubMed ID: 24488825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma cytokines and future risk of non-Hodgkin lymphoma (NHL): a case-control study nested in the Italian European Prospective Investigation into Cancer and Nutrition.
    Saberi Hosnijeh F; Krop EJ; Scoccianti C; Krogh V; Palli D; Panico S; Tumino R; Sacredote C; Nawroly N; Portengen L; Linseisen J; Vineis P; Vermeulen R
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1577-84. PubMed ID: 20501772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating immune markers and risks of non-Hodgkin lymphoma subtypes: A pooled analysis.
    Rhee J; Birmann BM; De Roos AJ; Epstein MM; Martinez-Maza O; Breen EC; Magpantay LI; Levin LI; Visvanathan K; Hosgood HD; Rohan TE; Smoller SW; Bassig BA; Qi L; Shu XO; Koh WP; Zheng W; Yuan JM; Weinstein SJ; Albanes D; Lan Q; Rothman N; Purdue MP
    Int J Cancer; 2023 Mar; 152(5):865-878. PubMed ID: 36151863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediagnostic circulating carotenoid levels and the risk of non-Hodgkin lymphoma: the Multiethnic Cohort.
    Ollberding NJ; Maskarinec G; Conroy SM; Morimoto Y; Franke AA; Cooney RV; Wilkens LR; Le Marchand L; Goodman MT; Hernandez BY; Henderson BE; Kolonel LN
    Blood; 2012 Jun; 119(24):5817-23. PubMed ID: 22550343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediagnostic leptin, adiponectin, C-reactive protein, and the risk of postmenopausal breast cancer.
    Ollberding NJ; Kim Y; Shvetsov YB; Wilkens LR; Franke AA; Cooney RV; Maskarinec G; Hernandez BY; Henderson BE; Le Marchand L; Kolonel LN; Goodman MT
    Cancer Prev Res (Phila); 2013 Mar; 6(3):188-95. PubMed ID: 23466816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipokines and inflammation markers and risk of differentiated thyroid carcinoma: The EPIC study.
    Dossus L; Franceschi S; Biessy C; Navionis AS; Travis RC; Weiderpass E; Scalbert A; Romieu I; Tjønneland A; Olsen A; Overvad K; Boutron-Ruault MC; Bonnet F; Fournier A; Fortner RT; Kaaks R; Aleksandrova K; Trichopoulou A; La Vecchia C; Peppa E; Tumino R; Panico S; Palli D; Agnoli C; Vineis P; Bueno-de-Mesquita HBA; Peeters PH; Skeie G; Zamora-Ros R; Chirlaque MD; Ardanaz E; Sánchez MJ; Ramón Quirós J; Dorronsoro M; Sandström M; Nilsson LM; Schmidt JA; Khaw KT; Tsilidis KK; Aune D; Riboli E; Rinaldi S
    Int J Cancer; 2018 Apr; 142(7):1332-1342. PubMed ID: 29168186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrocyte membrane fatty acid composition, serum lipids, and non-Hodgkin's lymphoma risk in a nested case-control study: the multiethnic cohort.
    Morimoto Y; Conroy SM; Ollberding NJ; Henning SM; Franke AA; Wilkens LR; Goodman MT; Hernandez BY; Le Marchand L; Henderson BE; Kolonel LN; Maskarinec G
    Cancer Causes Control; 2012 Oct; 23(10):1693-703. PubMed ID: 22907421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating inflammatory cytokines and adipokines are associated with increased risk of Barrett's esophagus: a case-control study.
    Garcia JM; Splenser AE; Kramer J; Alsarraj A; Fitzgerald S; Ramsey D; El-Serag HB
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):229-238.e3. PubMed ID: 23954649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Association of Pre-diagnostic Inflammatory Markers and Adipokines and the Risk of Non-Hodgkin Lymphoma Development in Egypt.
    El Demerdash DM; Tawfik NM; Elazab R; El Sissy MH
    Indian J Hematol Blood Transfus; 2021 Jan; 37(1):76-81. PubMed ID: 33707838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuated adiponectin, omentin, increased interleukin-6 and tumor necrosis factor-alpha levels with altered cognition and depression in non-Hodgkin lymphoma patients: A case-control study.
    Kathpalia M; Mishra P; Majid A; Khan MA; Sharma A; Bhurani D; Nidhi
    J Neuroimmunol; 2024 Jul; 392():578372. PubMed ID: 38788317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating inflammation markers and prospective risk for lung cancer.
    Shiels MS; Pfeiffer RM; Hildesheim A; Engels EA; Kemp TJ; Park JH; Katki HA; Koshiol J; Shelton G; Caporaso NE; Pinto LA; Chaturvedi AK
    J Natl Cancer Inst; 2013 Dec; 105(24):1871-80. PubMed ID: 24249745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of some inflammatory markers in patients with lymphoma.
    Hamed Anber N; El-Sebaie AH; Darwish NHE; Mousa SA; Shamaa SS
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30814315
    [No Abstract]   [Full Text] [Related]  

  • 16. A prospective analysis of body size during childhood, adolescence, and adulthood and risk of non-Hodgkin lymphoma.
    Bertrand KA; Giovannucci E; Zhang SM; Laden F; Rosner B; Birmann BM
    Cancer Prev Res (Phila); 2013 Aug; 6(8):864-73. PubMed ID: 23803416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediagnostic immunoglobulin E levels and risk of chronic lymphocytic leukemia, other lymphomas and multiple myeloma-results of the European Prospective Investigation into Cancer and Nutrition.
    Nieters A; Łuczyńska A; Becker S; Becker N; Vermeulen R; Overvad K; Aleksandrova K; Boeing H; Lagiou P; Trichopoulos D; Trichopoulou A; Krogh V; Masala G; Panico S; Tumino R; Sacerdote C; Bueno-de-Mesquita B; Jeurnink SM; Weiderpass E; Ardanaz E; Chirlaque MD; Sánchez MJ; Sánchez S; Borgquist S; Butt S; Melin B; Späth F; Rinaldi S; Brennan P; Kelly RS; Riboli E; Vineis P; Kaaks R
    Carcinogenesis; 2014 Dec; 35(12):2716-22. PubMed ID: 25269801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum adiponectin as a predictor of childhood non-Hodgkin's lymphoma: a nationwide case-control study.
    Petridou ET; Sergentanis TN; Dessypris N; Vlachantoni IT; Tseleni-Balafouta S; Pourtsidis A; Moschovi M; Polychronopoulou S; Athanasiadou-Piperopoulou F; Kalmanti M; Mantzoros CS
    J Clin Oncol; 2009 Oct; 27(30):5049-55. PubMed ID: 19738128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of 67 serum immune and inflammation markers and risk of non-Hodgkin lymphoma.
    Purdue MP; Hofmann JN; Kemp TJ; Chaturvedi AK; Lan Q; Park JH; Pfeiffer RM; Hildesheim A; Pinto LA; Rothman N
    Blood; 2013 Aug; 122(6):951-7. PubMed ID: 23814017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating inflammation markers and risk of epithelial ovarian cancer.
    Clendenen TV; Lundin E; Zeleniuch-Jacquotte A; Koenig KL; Berrino F; Lukanova A; Lokshin AE; Idahl A; Ohlson N; Hallmans G; Krogh V; Sieri S; Muti P; Marrangoni A; Nolen BM; Liu M; Shore RE; Arslan AA
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):799-810. PubMed ID: 21467242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.